Prestige Consumer Healthcare (PBH) Other Non-Current Assets (2011 - 2025)

Prestige Consumer Healthcare's (PBH) quarterly Other Non-Current Assets came in at $3.8 million in Q4 2025, down 40.16% year-on-year from $6.3 million in Q4 2024, and up 10.2% quarter-over-quarter from $3.4 million in Q3 2025.

Prestige Consumer Healthcare (PBH) Other Non-Current Assets (2011 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Other Non-Current Assets history runs 15 years deep, the most recent figure standing at $3.8 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets fell 40.16% year-over-year to $3.8 million in Q4 2025; TTM through Dec 2025 was $3.8 million, a 40.16% decrease from a year earlier, with the FY2025 full-year figure at $3.3 million, down 42.83% from the prior year.
  • Other Non-Current Assets climbed to $3.8 million in Q4 2025 per PBH's latest filing, from $3.4 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $6.7 million in Q3 2024 and bottomed at $2.5 million in Q2 2021.
  • The 5-year median for Other Non-Current Assets is $3.3 million (2022), against an average of $3.9 million.
  • Across the five-year window, Other Non-Current Assets jumped 99.84% in 2023 and plunged 51.48% in 2025, its largest moves.
  • Year by year, Other Non-Current Assets stood at $2.9 million in 2021, then increased by 9.13% to $3.2 million in 2022, then soared by 99.84% to $6.3 million in 2023, then grew by 0.57% to $6.3 million in 2024, then plunged by 40.16% to $3.8 million in 2025.
  • Per Business Quant, the three latest PBH Other Non-Current Assets figures stand at $3.8 million (Q4 2025), $3.4 million (Q3 2025), and $3.0 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Prestige Consumer Healthcare 2.34 Bn 2.28 Bn 157.37 Mn 3.79 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.79 Mn
Sep 30, 2025 3.44 Mn
Jun 30, 2025 3.02 Mn
Mar 31, 2025 3.27 Mn
Dec 31, 2024 6.34 Mn
Sep 30, 2024 6.73 Mn
Jun 30, 2024 6.23 Mn
Mar 31, 2024 5.73 Mn
Dec 31, 2023 6.30 Mn
Sep 30, 2023 3.86 Mn
Jun 30, 2023 3.27 Mn
Mar 31, 2023 3.01 Mn
Dec 31, 2022 3.15 Mn
Sep 30, 2022 2.58 Mn
Jun 30, 2022 2.74 Mn
Mar 31, 2022 3.27 Mn
Dec 31, 2021 2.89 Mn
Sep 30, 2021 2.56 Mn
Jun 30, 2021 2.52 Mn
Mar 31, 2021 2.86 Mn